Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal recessive muscular dystrophy caused by mutations in the POMT2 gene. It is associated with characteristic brain and eye malformations and profound mental retardation.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 7 | Hypoplasia of the brainstem, Seizure, Profound intellectual disability |
Muscles | 5 | Severe muscular hypotonia, Progressive muscle deterioration (muscular dystrophy), Congenital contracture |
Head and neck | 3 | Cleft palate, Microcephaly, Cleft upper lip |
Eyes | 2 | Cataract, Glaucoma |
Bones and joints | 2 | Sideways curvature of the spine (scoliosis), Skeletal muscle hypertrophy |
Lab test results | 1 | Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration) |
Pregnancy and birth | 1 | Congenital contracture |
POMT2 function has not been fully characterized.
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 is associated with mutations in the POMT2 gene on chromosome 14.
Genetic testing for POMT2 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 6 always present features, 9 common features.
No clinical trials have been registered for muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2.
119 publications have been identified in PubMed for muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2. Kisho has analyzed 91 by research type. Research spans Other (43%), Review / Meta-Analysis (25%), and Epidemiology / Natural History (14%).
Research Type | Count | % of Total |
|---|---|---|
Other research | 39 | 43% |
Research summaries | 23 | 25% |
Disease patterns and progression | 13 | 14% |
Patient case studies | 8 | 9% |
Clinical study results | 6 | 7% |
Laboratory research | 2 | 2% |
Donohue GF (2026). [PMID: 41793381](https://pubmed.ncbi.nlm.nih.gov/41793381/). *Eur J Pain*. [Review / Meta-Analysis]
Sheng D (2026). [PMID: 41851046](https://pubmed.ncbi.nlm.nih.gov/41851046/). *Alzheimers Dement*. [Epidemiology / Natural History]
Zhang J (2026). [PMID: 42158226](https://pubmed.ncbi.nlm.nih.gov/42158226/). *Clin Case Rep*. [Case Report / Case Series]
Cyriac J (2026). [PMID: 41324838](https://pubmed.ncbi.nlm.nih.gov/41324838/). *J Relig Health*. [Review / Meta-Analysis]
Jayanna S (2026). [PMID: 41930014](https://pubmed.ncbi.nlm.nih.gov/41930014/). *Oman J Ophthalmol*. [Case Report / Case Series]
Li S (2026). [PMID: 41379706](https://pubmed.ncbi.nlm.nih.gov/41379706/). *J Fam Psychol*. [Review / Meta-Analysis]
Schroeder RL (2026). [PMID: 41064951](https://pubmed.ncbi.nlm.nih.gov/41064951/). *Vet Pathol*. [Basic Science / Preclinical]
Sugiyama R (2025). [PMID: 39798169](https://pubmed.ncbi.nlm.nih.gov/39798169/). *Neuromuscul Disord*. [Epidemiology / Natural History]
Liu FQ (2025). [PMID: 40186435](https://pubmed.ncbi.nlm.nih.gov/40186435/). *J Ultrasound Med*. [Clinical Trial Publication]
Song JH (2025). [PMID: 40884152](https://pubmed.ncbi.nlm.nih.gov/40884152/). *Int J Psychol*. [Other]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 4:39 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center